From: Clara cell protein in bronchoalveolar lavage fluid: a predictor of ventilator-associated pneumonia?
Parameter | VAP | Non-VAP | P value |
---|---|---|---|
Number of patients | 79 | 117 | Â |
Mean age in years (range) | 60 (19-84) | 58 (18-87) | 0.445 |
Male:female ratio | 1.6:1 | 1.7:1 | 0.887 |
Mortality rate (%) | 44 | 36 | 0.324 |
Median hospital stay in days (range) | 47 (7-540) | 47 (6-297) | 0.289 |
Median ICU stay in days (range) | 43 (6-484) | 46 (1-291) | 0.454 |
Median days of intubation (range) | 8 (1-172) | 8 (1-198) | 0.289 |
Reason for admission, number of patients (%) | Â | Â | Â |
   Cardiac | 6 (7.6) | 12 (10.3) |  |
   Pulmonary | 14 (17.8) | 27 (23.1) |  |
   Trauma | 14 (17.8) | 15 (12.8) |  |
   Surgery | 17 (21.5) | 15 (12.8) |  |
   Neurological | 10 (12.6) | 6 (5.1) |  |
   Malignancy | 5 (6.3) | 9 (7.7) |  |
   Vascular surgery | 6 (7.6) | 19 (16.2) |  |
   Other | 7 (8.3) | 14 (12.0) |  |
Median Clara cell protein concentration in ng/mL (range) | 3,019 (282-65,546) | 2,504 (62-30,240) | 0.03 |